NF-κB inhibition: A double-edged sword in cancer?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Cancer

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.EJCA.2006.01.011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

  2005cited by this paper
• Nuclear factor-κB inhibitors as sensitizers to anticancer drugs

  2005cited by this paper
• CDK4 regulation by TNFR1 and JNK is required for NF-κB–mediated epidermal growth control

  2005cited by this paper
• IKK Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

  2004cited by this paper
• Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition.

  2004cited by this paper
• Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma

  2004cited by this paper
• Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kappaB signaling.

  2004cited by this paper
• NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK.

  2004cited by this paper
• Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development

  2004cited by this paper
• The Transcription Factors c-rel and RelA Control Epidermal Development and Homeostasis in Embryonic and Adult Skin via Distinct Mechanisms

  2004cited by this paper
• NF-κB functions as a tumour promoter in inflammation-associated cancer

  2004cited by this paper
• Crosstalk between PARP-1 and NF-κB modulates the promotion of skin neoplasia

  2004cited by this paper
• An Anti-Tumor Necrosis Factor-α Antibody Inhibits the Development of Experimental Skin Tumors

  2003cited by this paper
• Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53.

  2003cited by this paper
• Involvement of NF-κB signalling in skin physiology and disease

  2003cited by this paper
• NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia

  2003cited by this paper
• NF-κB in cancer: a marked target

  2003cited by this paper
• Tumour necrosis factor α: a potential target for the therapy of solid tumours

  2003cited by this paper
• The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor

  2003cited by this paper
• Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.

  2003cited by this paper
• NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach.

  2003cited by this paper
• Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway

  2002cited by this paper
• TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2

  2002cited by this paper
• Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-κB

  2002cited by this paper
• Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer

  2002cited by this paper
• Series Introduction: The transcription factor NF-κB and human disease

  2001cited by this paper
• IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development

  2001cited by this paper
• Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB

  2001cited by this paper
• Impaired Preneoplastic Changes and Liver Tumor Formation in Tumor Necrosis Factor Receptor Type 1 Knockout Mice

  2000cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000cited by this paper
• The Molecular and Cellular Origins of Hodgkin's Disease

  2000cited by this paper
• Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

  2000cited by this paper
• The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance.

  2000cited by this paper
• HIV-1 entry inhibitors: Evading the issue

  1999cited by this paper
• Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts

  1999cited by this paper
• Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene

  1999cited by this paper
• Aberrant rel/nfkb genes and activity in human cancer

  1999cited by this paper
• Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

  1999cited by this paper
• Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

  1999cited by this paper
• Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis

  1999cited by this paper
• The I kappa B kinase: a master regulator of NF-kappa B, innate immunity, and epidermal differentiation.

  1999cited by this paper
• Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis

  1999cited by this paper
• Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms.

  1998cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

  1997cited by this paper
• Genetic approaches to study Rel/NF-κB/IκB function in mice

  1997cited by this paper
• Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

  1997cited by this paper
• Rel/NF-?B and I?B factors in oncogenesis

  1997cited by this paper
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death

  1996cited by this paper
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

  1996cited by this paper
• Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.

  1995cited by this paper
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

  1995cited by this paper
• Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB

  1995cited by this paper
• Structure, regulation and function of NF-kappa B.

  1994cited by this paper

• Cancer Gene Therapy Utilizing NF-κB-regulated Expression of a miRNA Targeting RelA.

  2026cites this paper
• Roles on antiproliferation, apoptosis, necrosis and proinflammation of Micromeria fruticosa subsp. brachycalyx essential oil obtained by hydrodistillation on lung cancer cells

  2025cites this paper
• Computational prediction of new therapeutic effects of probiotics

  2024cites this paper
• Micromeria fruticosa and Foeniculum vulgare essential oils inhibit melanoma cell growth and migration by targeting MMP9 and NFkB signaling

  2024cites this paper
• NF-κB-activated oncogene inhibition strategy for cancer gene therapy

  2024cites this paper
• S100 Calcium-Binding Protein A8 Functions as a Tumor-Promoting Factor in Renal Cell Carcinoma via Activating NF-κB Signaling Pathway

  2023cites this paper
• N-acetylcysteine combined with insulin attenuates myocardial injury in canines with type 1 diabetes mellitus by modulating TNF-α-mediated apoptotic pathways and affecting linear ubiquitination.

  2023cites this paper
• Shedding Light on NF-κB Functions in Cellular Organelles

  2022cites this paper
• RNA Editing in Glioma as a Sexually Dimorphic Prognostic Factor That Affects mRNA Abundance in Fatty Acid Metabolism and Inflammation Pathways

  2022cites this paper
• Molecular and immunological changes in blood of rats exposed to various doses of asbestos dust.

  2022cites this paper
• Molecular Mechanisms of Hepatic Dysfunction in Sickle Cell Disease: Lessons From The Townes Mouse Model.

  2022cites this paper
• Neuropeptide W Attenuates Oxidative Multi-Organ Injury in Rats Induced with Intra-Abdominal Sepsis

  2021cites this paper
• Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling

  2021cites this paper
• DHMEQ enhances the cytotoxic effect of cisplatin and carboplatin in ovarian cancer cell lines.

  2021cites this paper
• Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases

  2020cites this paper
• NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development

  2020cites this paper
• Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting telomeres

  2020cites this paper
• The Fire Within: NF-κB Involvement in Non–Small Cell Lung Cancer

  2020cites this paper
• Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1– and chemokines-mediated mechanisms

  2020cites this paper
• NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants

  2020cites this paper
• A Cell-Specific Nuclear Factor-Kappa B–Activating Gene Expression Strategy for Delivering Cancer Immunotherapy

  2019cites this paper
• Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting to telomere

  2019cites this paper
• Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients

  2019cites this paper
• PKR: A Kinase to Remember

  2019cites this paper
• NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival

  2018cites this paper
• Interleukin-1α as an intracellular alarmin in cancer biology.

  2018cites this paper
• Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.

  2018cites this paper
• Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems

  2017cites this paper
• Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

  2016cites this paper
• IκBζ: an emerging player in cancer

  2016cites this paper
• Overview of common dietary phytochemicals possessing antioxidant properties through Nrf2

  2016cites this paper
• Canonical NF‐κB signaling in hepatocytes acts as a tumor‐suppressor in hepatitis B virus surface antigen‐driven hepatocellular carcinoma by controlling the unfolded protein response

  2016cites this paper
• Role of the ubiquitin ligase KPC1 in NF-κB activation and tumor suppression

  2016cites this paper
• Evidence of cellular senescence during the development of estrogen-induced pituitary tumors.

  2015cites this paper
• Dual effects of human adipose tissue-derived mesenchymal stem cells in human lung adenocarcinoma A549 xenografts and colorectal adenocarcinoma HT-29 xenografts in mice.

  2015cites this paper
• KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.

  2015cites this paper
• Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.

  2015cites this paper
• Pattern Recognition Receptors and Aging

  2014cites this paper
• Relation between Hypoxic Markers P65, P50, CAIX, and Tumor Stages in Invasive Ductal Carcinoma Subtypes

  2014cites this paper
• IFNAR1 Is a Predictor for Overall Survival in Colorectal Cancer and Its mRNA Expression Correlated With IRF7 But Not TLR9

  2014cites this paper
• Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches

  2014cites this paper
• Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis

  2014cites this paper
• Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies

  2014cites this paper
• Alternative Nf-kb Signaling in Atherogenesis

  2014cites this paper
• Identification of NF-κB Inhibitors from Watercress A Senior Honors Thesis Presented in Partial Fulfillment of the Requirements for Graduation with Distinction and Honors in Bachelor of Science of Pharmaceutical Sciences

  2013cites this paper
• Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null Mice

  2013cites this paper
• Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice

  2013cites this paper
• Apoptotic cells can induce non-autonomous apoptosis through the TNF pathway

  2013cites this paper
• Pleiotropic and Differential Functions of IL-1α and IL-1β Shape the Tumor Microenvironment and Affect the Outcome of Malignancies

  2013cites this paper
• The Regulation of the JNK Cascade and Programmed Cell Death by NF-κB: Mechanisms and Functions

  2013cites this paper
• Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression

  2012cites this paper
• Effects of Chorisia crispiflora Ethyl Acetate Extract on P21 and NF-κB in Breast Cancer Cells

  2012cites this paper
• The effect of the NF-kappa B inhibitors curcumin and lactacystin on myogenic differentiation of rhabdomyosarcoma cells.

  2012cites this paper
• Novel Marine Phenazines as Potential Cancer Chemopreventive and Anti-Inflammatory Agents

  2012cites this paper
• Novel Phosphorylation-dependent Ubiquitination of Tristetraprolin by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1) and Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)*

  2011cites this paper
• Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-κB-mediated bcl-2 activation

  2011cites this paper
• Colorectal cancer and NF-κB signaling pathway

  2011cites this paper
• NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?

  2011cites this paper
• Interacting Signaling Pathways in Mouse Skin Tumor Initiation and Progression

  2011cites this paper
• Signaling Pathways in the Liver

  2011cites this paper
• Emerging pathways and future targets for the molecular therapy of pancreatic cancer

  2011cites this paper
• Mechanisms of Weak Magnetic Field Influence on Gene Expression: Basics of Physical Epigenetics

  2011cites this paper
• Tumor necrosis factor-α induces epithelial–mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism

  2011cites this paper
• Expression of classical NF‐κB pathway effectors in human ovarian carcinoma

  2010cites this paper
• Dexamethasone enhances trichosanthin-induced apoptosis in the HepG2 hepatoma cell line.

  2010cites this paper
• Mechanisms of Geomagnetic Field Influence on Gene Expression Using Influenza as a Model System: Basics of Physical Epidemiology

  2010cites this paper
• Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth

  2010cites this paper
• In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model

  2010cites this paper
• NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia

  2010cites this paper
• Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma

  2009cites this paper
• Host-Derived Interleukin-1α Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells1

  2009cites this paper
• Nuclear Factor-Kappa B Inhibition Reduces Markedly Cell Proliferation in Epstein-Barr Virus-Infected Stomach Cancer, But Affects Variably in Epstein-Barr Virus-Negative Stomach Cancer

  2009cites this paper
• Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.

  2009cites this paper
• Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

  2009cites this paper
• Boswellia resin: from religious ceremonies to medical uses; a review of in‐vitro, in‐vivo and clinical trials

  2009cites this paper
• Potential pharmacological control of the NF-κB pathway.

  2009cites this paper
• 2-Methoxyestradiol mediated signaling network in pancreatic cancer.

  2009cites this paper
• 3-Methylcholantrene Tumor Cells Determining the Immunogenicity of Is Important in a Host-Derived Interleukin-1

  2009cites this paper
• Contradictory functions of NF-kappaB in liver physiology and cancer.

  2008cites this paper
• Prevention and Treatment of Head and Neck Cancer with Natural Compound Inhibitors of STAT3

  2008cites this paper
• Natural Killer Cells at the Tumors Microenvironment

  2008cites this paper
• Lornoxicam protects mouse cornea from UVB-induced damage via inhibition of NF-κB activation

  2008cites this paper
• Yin-yang activities and vicious cycles in the tumor microenvironment.

  2008cites this paper
• NF-κB: a new player in angiostatic therapy

  2008cites this paper
• RAGE signaling sustains inflammation and promotes tumor development

  2008cites this paper
• Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression.

  2008cites this paper
• NF‐κB as a potential molecular target for cancer therapy

  2007cites this paper
• NF‐κB activation in development and progression of cancer

  2007cites this paper
• Functional and Intracellular Signaling Differences Associated with the Helicobacter pylori AlpAB Adhesin from Western and East Asian Strains*

  2007cites this paper
• Targeting intracellular signaling: a novel approach to vaccination

  2007cites this paper
• Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils.

  2007cites this paper
• Molecular Regulation of Inflammatory Pain and Hyperalgesia - Is NF-?B the Lynchpin?

  2007cites this paper
• TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer

  2007cites this paper
• The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer

  2007cites this paper
• NF-κB as a target for cancer therapy

  2007cites this paper
• Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells.

  2007cites this paper
• Review article: Molecular Regulation of Inflammatory Pain and Hyperalgesia - Is NF-κB the Lynchpin? Focus Article and Critical Review

  2007cites this paper
• Epithelial NF-κB maintains host gut microflora homeostasis

  2007cites this paper
• S100A8 and S100A9 in inflammation and cancer.

  2006cites this paper
• Control of B Lymphocyte Apoptosis by the Transcription Factor NF-κB

  2006cites this paper